businesspress24.com - ISTA Pharmaceuticals Announces Conference Call and Webcast of Third Quarter 2011 Financial Results
 

ISTA Pharmaceuticals Announces Conference Call and Webcast of Third Quarter 2011 Financial Results

ID: 1046869

(firmenpresse) - IRVINE, CA -- (Marketwire) -- 10/18/11 -- ISTA Pharmaceuticals, Inc. (NASDAQ: ISTA), today announced it will release third quarter 2011 financial results after the market closes on November 1, 2011. In conjunction, the Company will host a conference call at 4:30 p.m. Eastern Time to review the Company's commercial operations and provide pipeline updates.

Date: Tuesday, November 1, 2011
Time: 4:30 p.m. Eastern Time

Conference call access:
Internet:
Domestic dial-in: 866.825.1692
International dial-in: 617.213.8059
Passcode: 90996630

To access the 24-hour audio replay, U.S. and Canadian participants may dial 888.286.8010; international participants may dial 617.801.6888. The access code for the replay is 93234261. This conference call will be webcast live and archived on ISTA's website until December 2, 2011.



ISTA Pharmaceuticals, Inc. is a fast growing and the third largest branded prescription eye care business in the United States with an expanding focus on allergy therapeutics. ISTA currently markets four products, including treatments for ocular inflammation and pain post-cataract surgery, glaucoma and ocular itching associated with allergic conjunctivitis. The company's development pipeline contains additional candidates in various stages of development to treat dry eye, ocular inflammation and pain, and nasal allergies. Headquartered in Irvine, California, ISTA generated revenues of $156.5 million in 2010. For additional information about ISTA, please visit the corporate website at .



Investor Relations Contacts at ISTA Pharmaceuticals, Inc.:
Lauren Silvernail
949-788-5302


Jeanie Herbert
949-789-3159


Media and Additional Investor Relations Contacts at Burns McClellan:
Justin Jackson
(Media)
212-213-0006


Juliane Snowden
(Investor Relations)
212-213-0006




Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:



Leseranfragen:



PresseKontakt / Agentur:



drucken  als PDF  an Freund senden  Reflect Scientific, Inc. Introduces Cryometrix Model B-120 Blast Freezer
AVI BioPharma Announces Data Presentation for RNA-Based Duchenne Muscular Dystrophy Drug Candidate at the 16th International World Muscle Society Congress
Bereitgestellt von Benutzer: MARKET WIRE
Datum: 18.10.2011 - 05:30 Uhr
Sprache: Deutsch
News-ID 1046869
Anzahl Zeichen: 0

contact information:
Contact person:
Town:

IRVINE, CA


Phone:

Kategorie:

Biotech


Anmerkungen:


Diese Pressemitteilung wurde bisher 66 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"ISTA Pharmaceuticals Announces Conference Call and Webcast of Third Quarter 2011 Financial Results
"
steht unter der journalistisch-redaktionellen Verantwortung von

ISTA Pharmaceuticals (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von ISTA Pharmaceuticals



 

Who is online

All members: 10 568
Register today: 1
Register yesterday: 2
Members online: 0
Guests online: 62


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.